Results 141 to 150 of about 6,539 (200)

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation.

Int Arch Allergy Immunol
Özden Ş, Tepetam FM, Bozkurt Y, Terzioğlu Şahin F, Aynacı A, Avcı HF, Dursun M, Demirkol MA, Yıldırım N.   +8 more
europepmc   +1 more source

Individualized precision therapy for severe asthma: clinical applications of biological agents and frontiers of cell therapy. [PDF]

Front Immunol
Chen G, Wang C, Han Y, Jiang Z.
europepmc   +1 more source

Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]

BMJ Open
Taylor H, Rahman N.
europepmc   +1 more source

Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: Benralizumab. [PDF]

Front Immunol
Saadia A, Wald R, Potruch A, Pizov G, Meir K, Gorin K, Sarig I, Dori EB, Rubin L, Ribak Y, Shamriz O, Tal Y, Talmon A.   +12 more
europepmc   +1 more source

The Therapeutic Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Review of the Current Evidence. [PDF]

Ther Clin Risk Manag
Chen W, Wen Y, Wang J, Meng X, Su L, Wu Y.   +5 more
europepmc   +1 more source

Can Coexisting Allergic Rhinitis in Patients with Severe Eosinophilic Asthma Be a Prognostic Factor for Efficacy of Biological Therapy? Analysis of Eosinophilic Involvement. [PDF]

J Clin Med
Jura-Szołtys E, Glück J, Klimek L, Gawlik R.   +3 more
europepmc   +1 more source

Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study. [PDF]

Front Immunol
Talmon A, Shamriz O, Rubin L, Ribak Y, Aynor I, Nevo A, Elia A, Sion MB, Forkosh E, Hershko AY, Tal Y.   +10 more
europepmc   +1 more source

Using biomarkers and independent predictors of therapy response to optimize treatment of uncontrolled severe asthma in the biologic era. [PDF]

Front Allergy
Yasui H.
europepmc   +1 more source

COPD 2.0: Bronchodilators, biologics and beyond - A systematic review. [PDF]

Lung India
Shamim H, Singh AK, Sharma R, Mishra RK.
europepmc   +1 more source

Evaluation of the concordance of asthma remission definitions according to international guidelines in a cohort of patients treated with monoclonal antibodies for severe asthma. [PDF]

Front Pharmacol
Ledda AG, Costanzo G, Canalis S, Puci MV, Sambugaro G, Taurisano G, Piano E, Bullita M, Sotgiu G, Firinu D, Del Giacco S.   +10 more
europepmc   +1 more source